Cargando…
Single-cell multiomic analysis of thymocyte development reveals drivers of CD4(+) T cell and CD8(+) T cell lineage commitment
The development of CD4(+) T cells and CD8(+) T cells in the thymus is critical to adaptive immunity and is widely studied as a model of lineage commitment. Recognition of self-peptide major histocompatibility complex (MHC) class I or II by the T cell antigen receptor (TCR) determines the CD8(+) or C...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457207/ https://www.ncbi.nlm.nih.gov/pubmed/37580604 http://dx.doi.org/10.1038/s41590-023-01584-0 |
Sumario: | The development of CD4(+) T cells and CD8(+) T cells in the thymus is critical to adaptive immunity and is widely studied as a model of lineage commitment. Recognition of self-peptide major histocompatibility complex (MHC) class I or II by the T cell antigen receptor (TCR) determines the CD8(+) or CD4(+) T cell lineage choice, respectively, but how distinct TCR signals drive transcriptional programs of lineage commitment remains largely unknown. Here we applied CITE-seq to measure RNA and surface proteins in thymocytes from wild-type and T cell lineage-restricted mice to generate a comprehensive timeline of cell states for each T cell lineage. These analyses identified a sequential process whereby all thymocytes initiate CD4(+) T cell lineage differentiation during a first wave of TCR signaling, followed by a second TCR signaling wave that coincides with CD8(+) T cell lineage specification. CITE-seq and pharmaceutical inhibition experiments implicated a TCR–calcineurin–NFAT–GATA3 axis in driving the CD4(+) T cell fate. Our data provide a resource for understanding cell fate decisions and implicate a sequential selection process in guiding lineage choice. |
---|